Neuraxis announces Capital Blue Cross Medical Policy Coverage for PENFS

NeurAxis (NRXS) announced medical policy coverage for Percutaneous Electrical Nerve Field Stimulation, PENFS, for Capital Blue Cross Medical Members, effective October 1, 2024. Capital Blue Cross serves a 21-county region in Central Pennsylvania and the Lehigh Valley. “We are excited regarding our coverage with Capital Blue Cross, further solidifying our patient reach in the Central Pennsylvania region,” said Brian Carrico, President and Chief Executive Officer of NeurAxis. “The strong body of published research has resulted in the increased acceptance of our PENFS technology, including expanding payer coverage, as well as the recent establishment of a new CPT Category I code, effective January 1, 2026, by the American Medical Association.” Mr. Carrico concluded.